Panalpina Bogota is company’s 31st location to gain GDP certification

Aug 28, 2018: Panalpina Bogota becomes the company’s 31st location globally to obtain WHO Good Distribution Practice (GDP) certification, an important international standard for the proper distribution of medicinal products for human use.

Colombia is Latin America’s fourth largest pharmaceutical market after Brazil, Mexico and Panama. 82 percent of Colombia’s pharmaceutical imports and 47 percent of the pharmaceutical exports run through the Bogota region.

The logistics giant’s business unit in Bogota, Colombia, has successfully completed a two-day audit by the world's leading inspection, verification, testing and certification company SGS, and is now certified according to international WHO Good Distribution Practice (GDP).

“We are proud about this achievement, and this is great news for our healthcare buy xanax online customers who demand strict quality and temperature control measures in the supply chain to ensure the safety and integrity of their products,” says Angelo Dotto, Panalpina’s managing director for Colombia.

Panalpina entered the Colombian market in 1962 and today has own offices in Bogota (head office), Medellín, Cali, Cartagena, Barranquilla, and Pereira, as well as an agent office in Buenaventura.

The company provides many of the world’s biggest pharmaceutical companies with international air and ocean freight as well as value-added logistics services.

“We see great growth potential in this business area, considering that the growth rate of this industry in Colombia is five percent per year,” comments Dotto.